DK0531078T3 - (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form - Google Patents

(R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form

Info

Publication number
DK0531078T3
DK0531078T3 DK92307903.2T DK92307903T DK0531078T3 DK 0531078 T3 DK0531078 T3 DK 0531078T3 DK 92307903 T DK92307903 T DK 92307903T DK 0531078 T3 DK0531078 T3 DK 0531078T3
Authority
DK
Denmark
Prior art keywords
methyl
trifluorobutylcarbamoyl
ylmethyl
methoxy
benzamide
Prior art date
Application number
DK92307903.2T
Other languages
Danish (da)
English (en)
Inventor
Murray Watson Cuthbert
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of DK0531078T3 publication Critical patent/DK0531078T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK92307903.2T 1991-09-05 1992-09-01 (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form DK0531078T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (1)

Publication Number Publication Date
DK0531078T3 true DK0531078T3 (da) 1996-10-14

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92307903.2T DK0531078T3 (da) 1991-09-05 1992-09-01 (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form

Country Status (21)

Country Link
US (2) US5352694A (ja)
EP (1) EP0531078B1 (ja)
JP (1) JP2914414B2 (ja)
KR (1) KR100254710B1 (ja)
AT (1) ATE138910T1 (ja)
AU (1) AU646587B2 (ja)
CA (1) CA2076722A1 (ja)
CZ (1) CZ281999B6 (ja)
DE (1) DE69211258T2 (ja)
DK (1) DK0531078T3 (ja)
FI (1) FI102372B (ja)
GB (2) GB9119001D0 (ja)
HK (1) HK18297A (ja)
HU (2) HU213410B (ja)
IL (1) IL102856A (ja)
NO (1) NO178370C (ja)
NZ (1) NZ244016A (ja)
RU (1) RU2095348C1 (ja)
SK (1) SK267092A3 (ja)
TW (1) TW302359B (ja)
ZA (1) ZA926374B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) * 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
EP1765333A4 (en) 2004-07-14 2008-06-18 Inflammation Res Ct Company Lt PROCESS FOR INHIBITING TUMOR METASTASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
FI102372B1 (fi) 1998-11-30
HU213410B (en) 1997-06-30
CZ281999B6 (cs) 1997-04-16
NZ244016A (en) 1995-01-27
NO923467D0 (no) 1992-09-04
NO178370B (no) 1995-12-04
KR930005976A (ko) 1993-04-20
HK18297A (en) 1997-02-13
ATE138910T1 (de) 1996-06-15
JPH05194385A (ja) 1993-08-03
KR100254710B1 (ko) 2000-05-01
AU2101292A (en) 1993-03-11
GB9216774D0 (en) 1992-09-23
ZA926374B (en) 1993-03-05
HUT69696A (en) 1995-09-28
HU9202660D0 (en) 1992-10-28
DE69211258D1 (de) 1996-07-11
IL102856A (en) 1996-12-05
RU2095348C1 (ru) 1997-11-10
DE69211258T2 (de) 1996-10-02
SK279657B6 (sk) 1999-02-11
NO178370C (no) 1996-03-13
NO923467L (no) 1993-03-08
FI923869A (fi) 1993-03-06
GB9119001D0 (en) 1991-10-23
HU210879A9 (en) 1995-09-28
SK267092A3 (en) 1999-02-11
US5466826A (en) 1995-11-14
US5352694A (en) 1994-10-04
JP2914414B2 (ja) 1999-06-28
IL102856A0 (en) 1993-01-31
EP0531078A1 (en) 1993-03-10
TW302359B (ja) 1997-04-11
AU646587B2 (en) 1994-02-24
FI102372B (fi) 1998-11-30
CA2076722A1 (en) 1993-03-06
EP0531078B1 (en) 1996-06-05
FI923869A0 (fi) 1992-08-28
CZ267092A3 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
IL167168A (en) Indoline compound in crystalline form for use in oral solid medicament and such oral solid medicament for treating dysuria
AU5884194A (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
CA2296604A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
KR970703333A (ko) 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists)
NZ242104A (en) Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof
NO912511D0 (no) Fremgangsmaate for forhindring eller begrensning av reperfusjonsskade
DK0531078T3 (da) (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form
HUP0203884A2 (hu) Kristályos oximinoalkánsav-származékok és cukorbaj elleni alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
CA2205573A1 (en) Enterokinetic benzamide
FI933719A (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
MXPA04000620A (es) Uso de derivados de tiazol para elaboracion de medicamento para tratamiento de enfermedad pulmonar obstructiva cronica.
ES2062940A1 (es) Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
CA2622808C (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
IT1237540B (it) Composta ad attivita' antiinfiammatoria ed anestetica,processo per la sua preparazione e composizioni che lo contengono